0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
69.45%
Positive revenue growth while 0335.HK is negative. John Neff might see a notable competitive edge here.
283.79%
Positive gross profit growth while 0335.HK is negative. John Neff would see a clear operational edge over the competitor.
229.63%
Positive EBIT growth while 0335.HK is negative. John Neff might see a substantial edge in operational management.
229.63%
Positive operating income growth while 0335.HK is negative. John Neff might view this as a competitive edge in operations.
183.19%
Net income growth of 183.19% while 0335.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
171.60%
EPS growth of 171.60% while 0335.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
171.60%
Diluted EPS growth of 171.60% while 0335.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
16.23%
Share count expansion well above 0335.HK's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
16.16%
Diluted share change of 16.16% while 0335.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-5.02%
Negative OCF growth while 0335.HK is at 50.60%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-3.95%
Negative FCF growth while 0335.HK is at 50.59%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-25.20%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-14.92%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
78.46%
3Y revenue/share CAGR similar to 0335.HK's 82.86%. Walter Schloss would assume both companies experience comparable short-term cycles.
-879.87%
Negative 10Y OCF/share CAGR while 0335.HK stands at 1063.42%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-38.06%
Negative 5Y OCF/share CAGR while 0335.HK is at 328.28%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2020.15%
Negative 3Y OCF/share CAGR while 0335.HK stands at 221.25%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
618.94%
Below 50% of 0335.HK's 4289.58%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
82.63%
Below 50% of 0335.HK's 11388.80%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
135.49%
Below 50% of 0335.HK's 2011.04%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
109.13%
10Y equity/share CAGR at 75-90% of 0335.HK's 130.29%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
-16.14%
Negative 5Y equity/share growth while 0335.HK is at 21.34%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
41.33%
3Y equity/share CAGR above 1.5x 0335.HK's 6.60%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-91.69%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.95%
AR growth of 8.95% while 0335.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-33.37%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-10.25%
Negative asset growth while 0335.HK invests at 6.10%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.50%
We have a declining book value while 0335.HK shows 0.30%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-55.61%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.41%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
71.83%
SG&A growth well above 0335.HK's 2.33%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.